Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation.

Published byKarl-Erik Falk Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation."— Presentation transcript:

1 Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. Mice were inoculated with 5 × 105 B16F10 cells on day 0. (A and B) PlGF-2123–144–αCTLA4 and PlGF-2123–144–αPD-L1 (100 μg each), αCTLA4 and αPD-L1 (100 μg each), or PBS was administered on day 4. PlGF-2123–144–Abs and PBS were injected peritumorally (pt), and unmodified Abs were injected either intraperitoneally (ip) or peritumorally. Blood plasma was collected on days 5, 7, 9, and 11. Concentrations of (A) αCTLA4 and (B) PD-L1 in blood plasma were determined by ELISA [PBS, n = 6; Abs (intraperitoneally), n = 5; others, n = 8; mean ± SEM]. (C to F) PlGF-2123–144–αCTLA4 or unmodified αCTLA4 and αPD-L1 (500 μg each per injection) were injected peritumorally on days 4 and 7. On day 9, blood serum was collected, and concentrations of (C) TNFα and (D) IFN-γ and (E) ALT activity in serum were measured (mean ± SEM). (F) Histologic liver sections were obtained on day 8. The number of lymphocytic infiltration spots was counted and divided by area (mean ± SEM). (G) Sixteen-week-old male NOD mice were given 100 μg of PlGF-2123–144–αPD-L1 or unmodified αPD-L1 on days 0 and 2 and evaluated for the development of diabetes. All Ab injections were intradermal at the back skin. Clinical diabetes was defined as blood glucose concentrations of 250 mg/dl for three consecutive days. Statistical analyses were done using ANOVA with Tukey’s test. Kruskal-Wallis test followed by Dunn’s multiple comparison was used in (C) due to nonparametric data. Log-rank (Mantel-Cox) test was performed for diabetes-free survival curves. Two experimental repeats. *P < 0.05, **P < N.S., not significant. Jun Ishihara et al., Sci Transl Med 2017;9:eaan0401 Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works

Download ppt "Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation."

Similar presentations

IFN-γ antagonizes TGF-β in vivo.

IFN-γ antagonizes TGF-β in vivo.
IFN-γ activates the fibrinolytic system.

IFN-γ activates the fibrinolytic system.
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.

Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Neutrophil antifungal response in CCR2-depleted mice is rescued by adoptive transfer of CCR2+ monocytes or by treatment with recombinant IFNs. Neutrophil.

Neutrophil antifungal response in CCR2-depleted mice is rescued by adoptive transfer of CCR2+ monocytes or by treatment with recombinant IFNs. Neutrophil.
Fig. 5. Serum VEGF-C correlates with antitumor immune responses and PFS after immunotherapy in human metastatic melanoma patients. Serum VEGF-C correlates.

Fig. 5. Serum VEGF-C correlates with antitumor immune responses and PFS after immunotherapy in human metastatic melanoma patients. Serum VEGF-C correlates.
Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.
TPAD training protocol.

TPAD training protocol.
Mice with neutrophil-specific deletion of IFNLR1 or STAT1 succumb to IA. Mice with neutrophil-specific deletion of IFNLR1 or STAT1 succumb to IA. Conditional.

Mice with neutrophil-specific deletion of IFNLR1 or STAT1 succumb to IA. Mice with neutrophil-specific deletion of IFNLR1 or STAT1 succumb to IA. Conditional.
Fig. 2. Exposure of both TCR and CAR antigens diminishes efficacy of CAR8 but not CAR4 cells. Exposure of both TCR and CAR antigens diminishes efficacy.

Fig. 2. Exposure of both TCR and CAR antigens diminishes efficacy of CAR8 but not CAR4 cells. Exposure of both TCR and CAR antigens diminishes efficacy.
Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.

Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.
Fig. 7 Correlation of NHP and human ISGs.

Fig. 7 Correlation of NHP and human ISGs.
Fig. 6 In utero injection of inflammatory cytokines or adoptive transfer of activated T cells leads to pregnancy loss. In utero injection of inflammatory.

Fig. 6 In utero injection of inflammatory cytokines or adoptive transfer of activated T cells leads to pregnancy loss. In utero injection of inflammatory.
IFN-γ antagonizes TGF-β in vivo.

IFN-γ antagonizes TGF-β in vivo.
Fig. 2 Whisker deprivation accelerates and enhances behavioral recovery after right S1FP photothrombosis. Whisker deprivation accelerates and enhances.

Fig. 2 Whisker deprivation accelerates and enhances behavioral recovery after right S1FP photothrombosis. Whisker deprivation accelerates and enhances.
Fig. 2 AcPGP induces IL-8 and G-CSF release from human bronchial epithelial cells. AcPGP induces IL-8 and G-CSF release from human bronchial epithelial.

Fig. 2 AcPGP induces IL-8 and G-CSF release from human bronchial epithelial cells. AcPGP induces IL-8 and G-CSF release from human bronchial epithelial.
Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.

Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.
Immune-mediated tumor control by necroptotic cells requires NF-κB activation within dying cells but not MLKL-mediated cell lysis and DAMP release. Immune-mediated.

Immune-mediated tumor control by necroptotic cells requires NF-κB activation within dying cells but not MLKL-mediated cell lysis and DAMP release. Immune-mediated.
Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.

Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.
Fig. 4. PVSRIPO infection of DCs is sublethal, is marginally productive, and induces sustained proinflammatory cytokine production. PVSRIPO infection of.

Fig. 4. PVSRIPO infection of DCs is sublethal, is marginally productive, and induces sustained proinflammatory cytokine production. PVSRIPO infection of.
Fig. 3 M7824 inhibits tumor growth and metastasis and provides long-term antitumor immunity. M7824 inhibits tumor growth and metastasis and provides long-term.

Fig. 3 M7824 inhibits tumor growth and metastasis and provides long-term antitumor immunity. M7824 inhibits tumor growth and metastasis and provides long-term.

Similar presentations

Ads by Google